Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bodil-Cecilie Sondergaard
Observed name:
Bodil‐Cecilie Sondergaard
Institution:
Novo Nordisk (Denmark)
Observed institutions:
Novo Nordisk (Denmark),
Nordic Bioscience (Denmark)
OpenAlex ID:
A5110074879
Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase–mediated cartilage degradation, but not aggrecanase‐mediated cartilage degradation
2007
·
Morten Asser Karsdal
, Eren Ufuk Sumer
, et al.
·
Arthritis & Rheumatism
·
69
The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model
2007
·
Bodil‐Cecilie Sondergaard
, Svetlana Oestergaard
, et al.
·
Arthritis & Rheumatism
·
68
Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes
2010
·
Bodil-Cecilie Sondergaard
, Suzi H Madsen
, et al.
·
BMC Musculoskeletal Disorders
·
47
PDF
Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments
2009
·
Bijue Wang
, Pingping Chen
, et al.
·
BMC Research Notes
·
36
PDF
Aggrecanase- and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in timeex vivo
2009
·
Suzi Hoegh Madsen
, Eren Ufuk Sumer
, et al.
·
Biomarkers
·
33
Evaluating IL-21 as a Potential Therapeutic Target in Crohn’s Disease
2018
·
Thomas Lindebo Holm
, Ditte Tornehave
, et al.
·
Gastroenterology Research and Practice
·
27
PDF
Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model
2015
·
Sara M. Atkinson
, Anneline Nansen
, et al.
·
Autoimmunity
·
11
PDF
Show more works
View as search
Works count:
7
Citation count:
291
H-index:
7
I10-index:
7
Year
Topic
Type